MEK inhibitor resistance mechanisms and recent developments in combination trials

E Kun, YTM Tsang, CW Ng, DM Gershenson… - Cancer treatment …, 2021 - Elsevier
… evade MEK inhibition, and this often involves a re-wiring of the MAPK pathway to reactivate
… by which they can promote cell signaling, and reactivation of RTKs following MEK inhibition …

SHP2 inhibition overcomes RTK-mediated pathway reactivation in KRAS-mutant tumors treated with MEK inhibitors

H Lu, C Liu, R Velazquez, H Wang, LM Dunkl… - Molecular cancer …, 2019 - AACR
pathway reactivation in a large panel (n = 34) of KRAS-mutant cell lines, by measuring the
reduction of phospho-MEK … We also found that combining SHP2 and MEK inhibitors led to …

Targeting alterations in the RAF–MEK pathway

R Yaeger, RB Corcoran - Cancer discovery, 2019 - AACR
… However, incomplete pathway suppression or pathway reactivation is a major issue …
combined RAF and MEK inhibitors, as MEK inhibition can suppress the resultant ERK reactivation. …

[PDF][PDF] A systematic analysis of signaling reactivation and drug resistance

BN Kholodenko, N Rauch, W Kolch, OS Rukhlenko - Cell reports, 2021 - cell.com
… We show that no combination of feedbacks coming from the pathwayCombining two RAF
inhibitors blocks ERK pathway reactivation more effectively than combining RAF and MEK

[HTML][HTML] Synergistic inhibition of MEK and reciprocal feedback networks for targeted intervention in malignancy

Y Li, Q Dong, Y Cui - Cancer Biology & Medicine, 2019 - ncbi.nlm.nih.gov
… Second, the cotargeting of MEK and resistance pathways by combining MEKi with partner
… In summary, the reactivation of the PI3K-AKT-mTOR pathway and its complex crosstalk with …

[PDF][PDF] Kinetics of RTK activation determine ERK reactivation and resistance to dual BRAF/MEK inhibition in melanoma

S Kim, R Carvajal, M Kim, HW Yang - Cell Reports, 2023 - cell.com
… on the BRAF/MEK/ERK pathway.Combined BRAF inhibitor (BRAFi) and MEK inhibitor (MEKi) …
ERK pathway reactivation has also been observed in melanoma mouse models12 and …

Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signaling

R Tripathi, Z Liu, A Jain, A Lyon, C Meeks… - Nature …, 2020 - nature.com
… BRAF-independent activation of MEK, combining BRAF and MEK inhibitors (MEKi; eg … of
ERK-dependent signaling pathways since ERK reactivation is a common resistance mechanism…

Vertical Inhibition of the RAF–MEK–ERK Cascade Induces Myogenic Differentiation, Apoptosis, and Tumor Regression in H/NRASQ61X Mutant …

N Garcia, V Del Pozo, ME Yohe, CM Goodwin… - Molecular cancer …, 2022 - AACR
… We conclude that CRAF reactivation limits the activity of single-agent MEK/ERK inhibitors in
… how combining trametinib with SHP2, FGFR or ERK1/2 inhibitors affected MAPK pathway

Biological rationale for targeting MEK/ERK pathways in anti-cancer therapy and to potentiate tumour responses to radiation

F Marampon, C Ciccarelli, BM Zani - International journal of molecular …, 2019 - mdpi.com
… However, we reported that radiation combined with MEK/ERK inhibitor treatment in in vivo
… durable targets in MEK inhibition therapy, in which MAPK pathway reactivation occurs early, …

The synergistic antitumor effect of combination therapy with a MEK inhibitor and YAP inhibitor on pERK-positive neuroblastoma

M Takemoto, T Tanaka, R Tsuji, Y Togashi… - Biochemical and …, 2021 - Elsevier
… effects of trametinib, a MEK inhibitor, on neuroblastoma with MAPK pathway mutations. As
we … combination group, the tumors gradually grew after seven weeks with MAPK reactivation. …